PM meets global energy firm’s delegation
ISLAMABAD: Prime Minister Imran Khan met a delegation of leading global energy firm “VITOL” and its partner in Pakistan HASCOL along with Sahibzada Jahangir, Prime Minister’s spokesman on Trade & Investment for UK & Europe.
The prime minister was apprised of VITOL & HASCOL expansion and investment plans in the oil industry in Pakistan. Christopher Bake, Senior Director VITOL, Chairman HASCOL Mumtaz Hasan and CEO HASCOL Saleem Butt comprised the delegation. The VITOL and HASCO, along with Sahibzada Jahangir, also met Dr Abdul Hafeez Shaikh, Adviser to Prime Minister on Finance.
VITOL is an energy and commodities giant managing a global chain of Oil & LNG supplies with offices in 40 countries.
HASCOL is the leading private sector Oil Marketing and Distribution company in Pakistan with a developing portfolio of other energy products.
-
Savannah Guthrie Expresses Fresh Hope As Person Detained For Questioning Over Kidnapping Of Nancy -
ByteDance Suspends Viral Seedance 2.0 Photo-to-voice Feature: Here’s Why -
Tom Hanks Diabetes 2 Management Strategy Laid Bare -
Bad Bunny Wins Hearts With Sweet Gesture At Super Bowl Halftime Show -
Why Angelina Jolie Loves Her 'scars' Following Double Mastectomy -
‘World Is In Peril’: Anthropic AI Safety Researcher Resigns, Warns Of Global Risks -
Meghan Markle Receives Apology As Andrew Puts Monarchy In Much Bigger Scandal -
Catherine O’Hara Becomes Beacon Of Hope For Rectal Cancer Patients -
Nancy Guthrie: Is She Alive? Former FBI Director Shares Possibilities On 10th Day Of Kidnapping -
Siemens Energy Profit Surges Nearly Threefold Amid AI Boom For Gas Turbines, Grids -
TikTok's ByteDance To Develop Advance AI Chips With Samsung -
Princess Beatrice, Eugenie In Dilemma As Andrew, Fergie Scandal Continues -
Tumbler Ridge School Shooting Among Canada’s Deadliest — Here’s Where It Ranks -
Suspect Detained As Authorities Probe Nancy Guthrie’s Abduction -
Tumbler Ridge Tragedy: Nine Killed, 25 Injured After School Shooting In British Columbia -
FDA Sends 'refusal-to-file' To Moderna Over New Flu Vaccine